Rosiglitazone Alone Or in Combination with Tissue Plasminogen Activator Improves Ischemic Brain Injury in an Embolic Model in Rats
- 24 June 2009
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 29 (10), 1683-1694
- https://doi.org/10.1038/jcbfm.2009.87
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.Keywords
This publication has 49 references indexed in Scilit:
- Combination Therapy of Rosiglitazone, a Peroxisome Proliferator‐Activated Receptor‐γ Ligand, and NMDA Receptor Antagonist (MK‐801) on Experimental Embolic Stroke in RatsBasic & Clinical Pharmacology & Toxicology, 2007
- Effects of Rosiglitazone Alone and in Combination With Atorvastatin on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes MellitusThe American Journal of Cardiology, 2006
- Modulation of the oxidative stress and inflammatory response by PPAR-γ agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusionEuropean Journal of Pharmacology, 2006
- Multiple roles for MMPs and TIMPs in cerebral ischemiaGlia, 2005
- Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 Expression During Reperfusion InjuryStroke, 2002
- Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's diseaseJournal of Neurochemistry, 2002
- Peroxisome proliferator‐activated receptor‐γ agonists prevent experimental autoimmune encephalomyelitisAnnals of Neurology, 2002
- Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94Journal of Cerebral Blood Flow & Metabolism, 2000
- Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in strokeJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons.Stroke, 1991